Introduction
Open elective and non-elective aortic surgery have proven track record
in reducing mortality related intimal aortic disruption, however and
despite timely and specialized aortic surgical interventions, mortality
and morbidity remain inconsistent and wavering on multiple factors.
Amongst, the use of cardiopulmonary bypass and hypothermic circulatory
arrest are associated with coagulation related adverse
events.1 Moreover,
coagulopathy is related to urgency or setting of the operation.
Nonetheless, studies also correlated coagulopathy to type of pathology,
urgency, predictors implicating bleeding intraoperatively and
post-operatively. However, no robust evidence exists to implicate
utilization of aortic arch device technologies in the causation of
coagulopathy and the correlation to performance, applicability, and type
of frozen elephant trunk use. To this end, and given the rapid surge of
device technologies application and use in aortic arch surgery, we
sought to explore the development of coagulopathy and correlate this to
type of FET highlighting potential predictors to help aid clinical
decision making and framework.